Literature DB >> 22493036

Primary bilateral silicone frontalis suspension for good levator function ptosis in oculopharyngeal muscular dystrophy.

Richard C Allen1, M Bridget Zimmerman, Emily A Watterberg, Leslie A Morrison, Keith D Carter.   

Abstract

AIM: To evaluate outcomes of patients with oculopharyngeal muscular dystrophy (OPMD) with levator function (LF) ≥ 10mm who underwent primary bilateral silicone frontalis suspension.
METHODS: 31 patients with OPMD satisfied the following inclusion criteria: LF ≥ 10 mm; no previous eyelid surgery; and pre-operative measurements, silcone frontalis suspension and post-operative measurements performed by a single individual. The following data were collected: age; gender; pre-operative margin reflex distance (MRD), palpebral fissure height (PF), and LF; post-operative MRD, PF and lagophthalmos; follow-up; and complications.
RESULTS: Mean age at surgery was 61.5 ± 5.8 years. Pre-operative measurements for MRD, PF and LF were -0.05 ± 0.82 mm (OD), -0.13 ± 0.91 mm (OS); 5.2 ± 1.2 mm (OD), 5.2 ± 1.3 mm (OS); 11.6 ± 1.3 mm (OD), and 11.7 ± 1.3 mm (OS), respectively. Post-operative measurements for MRD and PF were 2.23 ± 0.97 mm (OD), 2.10 ± 1.09 mm (OS), 7.9 ± 1.4 mm (OD), and 7.7 ± 1.6 mm (OS), respectively (all p < 0.0001). The mean follow-up period was 22.8 ± 22.4 months. There was no sling (infection or extrusion) or ophthalmic (significant corneal compromise) complication after the surgery. Six patients (19%) underwent early (within 3 months) tightening of their slings for under correction. Three patients (10%) underwent late (> 39 months) tightening of their frontalis slings for recurrent ptosis after their initial surgery.
CONCLUSIONS: Primary bilateral silicone frontalis suspension for good LF ptosis secondary to OPMD appears to be an effective, safe treatment which gives symmetrical upper lid elevation. Early sling adjustment may be required to attain optimal eyelid height and late tightening for expectant loosening of the sling is safe and effective.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493036     DOI: 10.1136/bjophthalmol-2011-300667

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  3 in total

1.  Longitudinal clinical follow-up of a large family with the R357P Twinkle mutation.

Authors:  Carmen Paradas; Pilar Camaño; David Otaegui; Oguzhan Oz; Valentina Emmanuele; Salvatore DiMauro; Michio Hirano
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

Review 2.  Suspensory Materials for Surgery of Blepharoptosis: A Systematic Review of Observational Studies.

Authors:  Elena Pacella; Daniele Mipatrini; Fernanda Pacella; Giulia Amorelli; Andrea Bottone; Gianpaolo Smaldone; Paolo Turchetti; Giuseppe La Torre
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

3.  Frontalis muscle flap suspension for the correction of congenital blepharoptosis in early age children.

Authors:  Dianju Hou; Gehong Li; Lin Fang; Bing Li
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.